By 
October 23rd, 2018
Credit: SpaceLife Origin
A bio-tech company announced today a ‘Seeds-of-Life’ in space initiative by 2020, make human embryo conception feasible by 2021 and human birth by 2024.
SpaceLife Origin, based in The Netherlands, has entered in partnerships with universities and leading suppliers from the space technology and medical sector. The group has outlined a step-by-step methodology making use of unique patent pending technology to enable sustainable life beyond Earth.
Credit: SpaceLife Origin
Patent pending
Patent pending technology is the core of SpaceLife Origin Ark, which contains 1.000 protected tubes with human reproduction cells.
The Ark provides a safe, radiation shielded environment. The cells (male, female and 2-PN) are harvested in approved and supervised IVF clinics worldwide.
Credit: SpaceLife Origin
The cells are vitrified and stored safely in secure Earth locations and in a satellite in space. Protecting the cells for any catastrophic event on Earth for decades. The ultimate and most unique insurance for mankind. Real-time tracking and footage from cameras on board enable customers to view and show their ‘seeds-of-life’ cells in orbit.
Credit: SpaceLife Origin
Space embryos
According to the group, a new “Space-Embryo-Incubator” is to be sent into space containing male and female reproduction cells. Once in space the embryos are conceived and start developing. After four days, the incubator returns to Earth where the embryos are checked.
The actual pregnancies and births will occur on Earth.
For more information, go to:
https://spacelifeorigin.com/en
Go to this video at:
https://spacelifeorigin.com/uploads/video/SpaceLife_Origin_Trailer_v180601.mp4
Posted in Space News
